BioSpace News Archive

Business

Acticor Biotech Appoints Dr Andrea Comenducci as Medical Director

Acticor Biotech, announced the appointment of Dr Andrea Comenducci MD as Medical Director in charge of clinical R&D and medical affairs

December 18, 2018
·
2 min read
Business

Another Record Year for ZEISS

In fiscal year 2017/18 (ended on 30 September 2018), the company achieved record-breaking revenue and earnings

December 18, 2018
·
2 min read
Business

Elanco Announces 2019 Financial Guidance

2019 revenue is expected to be between $3.10 billion and $3.16 billion.

December 18, 2018
·
10 min read
Deals

AcelRx Pharmaceuticals added to the NASDAQ Biotechnology Index (NBI)

AcelRx Pharmaceuticals, Inc., announced it has been selected for addition to the NASDAQ Biotechnology Index®

December 18, 2018
·
1 min read
BioMidwest

Centene Rolls Out RxAdvance’s Transformative Pharmacy Benefit Model In Mississippi

Centene Corporation, announced that its Mississippi subsidiary, Magnolia Health, completed the implementation of a transformative pharmacy benefit management model using RxAdvance’s Collaborative PBM Cloud™ platform, covering 240,000 Mississippi Medicaid members.

December 18, 2018
·
8 min read
Policy

TerrAscend Controlled Entity Awarded One of Six Permits to Apply For Vertically Integrated Licenses in New Jersey

Permit to apply for cannabis cultivation, processing and retail operations in populous Northern New Jersey region

December 18, 2018
·
6 min read
Business

Phio Pharmaceuticals to Present at Biotech Showcase™ 2019 in San Francisco

Phio Pharmaceuticals Corp., announced that Dr. Gerrit Dispersyn, President and Chief Operating Officer, will present at Biotech Showcase™ 2019, to be held January 7 – 9, 2019 at the Hilton San Francisco Union Square.

December 18, 2018
·
3 min read
Business

Stoke Therapeutics Expands Senior Leadership Team, Adding Deep Expertise in Regulatory Affairs and Clinical Operations

Company also relocating to expanded R&D facilities at 45 Wiggins Ave. in Bedford, Mass.

December 18, 2018
·
4 min read
Business

Semma Therapeutics Expands Executive Leadership Team

Appoints David Lebwohl, M.D., as Chief Medical Officer, David DiGiusto, Ph.D., as Chief Technology Officer and Ann Darda as Head of Human Resources

December 18, 2018
·
2 min read
BioMidwest

RiverVest Venture Partners Closes on Oversubscribed $184.4 Million Life Sciences Fund

Life sciences venture capital firm RiverVest Venture Partners today announced the final closing of RiverVest Venture Fund IV, L.P., reaching $184.4 million in capital commitments in an oversubscribed fundraise.

December 18, 2018
·
2 min read